Home › NDC Lookup › RxCUI directory › RxCUI 1535150

Docosaenoic acid 300 MG / eicosapentaenoic acid 0.75 MG Oral Capsule — RxCUI 1535150

RxNorm drug concept · Semantic clinical drug
RxCUI 1535150 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1535150
Official nameDocosaenoic acid 300 MG / eicosapentaenoic acid 0.75 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)600 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Docosaenoic acid 300 MG / eicosapentaenoic acid... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Docosaenoic acid 300 MG / eicosapentaenoic acid 0.75 MG Oral Capsule RxCUI 1535150

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Docosaenoic acid 1291425
    • Eicosapentaenoate 618597
    • Docosaenoic acid / eicosapentaenoate 1291430
    • Eicosapentaenoic acid 90
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Docosaenoic acid / eicosapentaenoate Oral Capsule 1291429
    • Docosaenoic acid / eicosapentaenoic acid Oral Capsule 2648807
    • Docosaenoic acid / eicosapentaenoate Oral Product 1291427
    • Docosaenoic acid / eicosapentaenoate Pill 1291428
    • Docosaenoic acid / eicosapentaenoic acid Oral Product 2662518
    • Docosaenoic acid / eicosapentaenoic acid Pill 2660406
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Docosaenoic acid 300 MG 1535148
    • Eicosapentaenoic acid 0.75 MG 1535149

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Docosaenoic acid 300 MG SCDC · 1535148
  • Eicosapentaenoic acid 0.75 MG SCDC · 1535149
  • Docosaenoic acid / eicosapentaenoate Oral Capsule SCDF · 1291429
  • Docosaenoic acid / eicosapentaenoic acid Oral Capsule SCDFP · 2648807
  • Docosaenoic acid / eicosapentaenoate Oral Product SCDG · 1291427
  • Docosaenoic acid / eicosapentaenoate Pill SCDG · 1291428
  • Docosaenoic acid / eicosapentaenoic acid Oral Product SCDGP · 2662518
  • Docosaenoic acid / eicosapentaenoic acid Pill SCDGP · 2660406

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1535150 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00178-0891-30 30 BLISTER PACK in 1 CARTON (0178-0891-30) / 1 KIT in 1 BLI... CitraNatal Assure Mission Pharmacal Company 2014-04-30
Observed labelers: Mission Pharmacal Company (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.